Navigation Links
Study says therapeutics for trauma patients may not be effective due to an infection

A Kansas State University study aimed at alleviating intestinal damage in trauma patients digressed to an important finding that could affect medication given to the individuals.

Diana Hylton is a K-State senior in microbiology, nutritional sciences and pre-medicine. She is analyzing how the immune system is involved in damage to the intestines following hemorrhagic shock. While studying the effects of a complement inhibitor given following hemorrhage, she found that Helicobacter infection changes the body's mechanistic response and would therefore affect the therapeutics given to trauma patients.

"The understanding of the different immune processes involved after hemorrhage suggests that the therapeutic potential of some drugs might not be effective on trauma patients with undiagnosed Helicobacter infections," Hylton said.

Hylton is working with Sherry Fleming, assistant professor in the Division of Biology. Hylton's project involves studying a mouse model of hemorrhage, which is associated with a sudden rapid loss of a significant amount of blood, and it is common in trauma patients. Hemorrhage causes intestinal damage, and the body responds by activating the complement system.

The complement system is part of the body's natural immune mechanisms to defend against infections. However, uncontrolled and excessive activation can result in inflammatory tissue damage, so trauma victims are given therapeutics to stop the activation. If a therapeutic could stop complement activation briefly, trauma victims would get less tissue damage and improved survival and recovery because the natural immune functions would remain intact.

Hylton has been analyzing changes in the mouse model concerning the intestinal tissue injury and inflammatory response. During the study, the mice became infected with Helicobacter, which is a bacteria found in the intestines of animals and humans. The infection often does not show obvious symptoms and therefore is commonly undiagnosed, which causes ulcers as well as liver and colon cancer.

Hylton found that when Helicobacter infections are present, they dramatically change the mechanism causing intestinal injury after hemorrhage. Infected mice did not get intestinal damage from complement activation but rather a different component of the immune system was involved.

"Diana found that mice infected with Helicobacter sustain significant intestinal damage in response to hemorrhage, but it is not complement-mediated," Fleming said. "This is important, as many of the therapeutics for hemorrhage are aimed at stopping the complement system, and they do not improve the outcome of infected mice. Thus, trauma patients with undiagnosed infections may require different therapeutics."

Hylton is finishing her central project that involves using a complement inhibitor, administered after hemorrhage, to analyze the changes in the intestinal tissue injury and inflammatory response. The complement inhibitor is delivered locally to the intestinal tissue where complement is activated and binds to certain molecules that have covered the injured cells. This selective binding blocks any further undesirable complement activation that would injure the intestinal tissue.

"I am eager to learn more about how the immune response following hemorrhage is influenced by other immune cells and their secretions," Hylton said. "Cytokines are an exciting area of research because they can have different biological functions in different parts of the body and with different immune responses."

She said initial studies show that IL-12, a small non-antibody molecule that communicates between cells in the body, increases after hemorrhage and is blocked when complement is inhibited. By using mice that are IL-12 deficient, she is studying the pathways and cells involved in IL-12 production after hemorrhage.

Hylton has presented the Helicobacter research at the Annual Meeting of the Society of Leukocyte Biology and at the Annual K-State Research Forum. She presented both the Helicobacter and complement inhibitor research at the Kansas Institutional Development Award Network of Biomedical Research Excellence symposium.


Contact: Sherry Fleming
Kansas State University

Related medicine news :

1. Study Shows You Don't Need Wall Street Sized Bonuses to Raise Employee Morale
2. Treat Women With Heart Attack Just Like Men: Study
3. Autism Research Study Announced By Children's Health Council
4. Study to Identify Infants at High Risk for Developing Obesity
5. Blacks have highest cancer rates of all racial ethnicities, yet feel less at risk, study finds
6. Study: Mechanomyography to be accurate in detecting nerves during minimally invasive spine surgery
7. Mayo Clinic Proceedings study finds link between hypoglycemia and mortality rates in critically ill
8. Autism Consortium study in Pediatrics shows CMA finds more genetic abnormalities than current tests
9. Minimally invasive sports hernia repair may get athletes back in the game faster, study says
10. New study finds 70 percent of able-bodied hockey players have abnormal hip and pelvis MRIs
11. 15 years after ACL knee reconstruction, 84 percent of male patients still highly active, study says
Post Your Comments:
Related Image:
Study says therapeutics for trauma patients may not be effective due to an infection
(Date:6/24/2016)... ... June 24, 2016 , ... ... Scientific Sessions in Dallas that it will receive two significant new grants to ... came as PHA marked its 25th anniversary by recognizing patients, medical professionals and ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all ... brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway ... call for a minimum wage raise to $12 an hour by 2020 and then adjusting ... restore the lost value of the minimum wage, assure the wage floor does not erode ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB Medicine presented its ... Emergency Medicine conference in Ponte Vedra Beach, FL. The awards honor the outstanding ... Medicine Practice and Pediatric Emergency Medicine Practice. , “With this award, we ...
(Date:6/24/2016)... ... June 24, 2016 , ... Puradigm® & Innovative Solutions ... initiated cultivation and processing operations at its production facility, and opened its first ... is the manufacturer of a complete system of proactive air and surface purification ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... -- According to a new market research ... Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, 8mm, ... Purchase (Retail, Non-Retail) - Trends & Global Forecasts to ... for the forecast period of 2016 to 2021. This ... 2021 from USD 1.65 Billion in 2016, growing at ...
(Date:6/23/2016)... 23, 2016  MedSource announced today that it ... software solution of choice.  This latest decision demonstrates ... to their clients by offering a state-of-the-art electronic ... establishes nowEDC as the EDC platform of choice ... clients.  "nowEDC has long been a preferred EDC ...
Breaking Medicine Technology: